Novus Scientific has reported the three-year pre-clinical data of the adsorbable TIGR matrix surgical mesh versus a permanent mesh in a sheep model.

The results revealed that as TIGR matrix was absorbed over time, it was replaced by connective tissue that had higher collagen content than that surrounding the permanent control mesh.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The foreign-body response to TIGR matrix also declined, but it remained persistent in the control group.

Co-inventor of TIGR Matrix Henrik Hjort said a range of clinical studies are underway to examine the results of repair using the device in a variety of soft tissue reinforcement applications.

The study was conducted at Biomatech, an independent contract research company that is part of the NAMSA group.

The TIGR matrix surgical mesh is available in US and Europe.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact